Plasma catestatin predicts all-cause and cardiac death of heart failure patients

被引：0
|
作者：
Chu Songyun [1 ]
Peng Fen [1 ]
Liu Lin [1 ]
Li Renxu [1 ]
Wang Jie [1 ]
Ding Wenhui [1 ]
机构：
[1] Peking Univ, Hosp 1, Beijing, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 68卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW27-e0868
引用
收藏
页码：C148 / C148
页数：1
相关论文
共 50 条
  • [41] Heart valve sclerosis predicts all-cause and cardiovascular mortality
    Voelzke, Henry
    Haring, Robin
    Lorbeer, Roberto
    Wallaschofski, Henri
    Reffelmann, Thorsten
    Empen, Klaus
    Rettig, Rainer
    John, Ulrich
    Felix, Stephan B.
    Doerr, Marcus
    ATHEROSCLEROSIS, 2010, 209 (02) : 606 - 610
  • [42] National early warning score predicts 90 days all-cause mortality among patients with acute heart failure
    Caidi, N. O. E.
    Wisborg, F. W.
    Taraldsen, I. T.
    Kandiah, A. K.
    El-Sheikh, M. S.
    Hove, J. H.
    Grand, J. G.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [43] The association of comorbid diabetes mellitus and symptoms of depression with all-cause mortality and cardiac rehospitalization in patients with heart failure
    Reeves, Geri C.
    Alhurani, Abdullah S.
    Frazier, Susan K.
    Watkins, John F.
    Lennie, Terry A.
    Moser, Debra K.
    BMJ OPEN DIABETES RESEARCH & CARE, 2015, 3 (01):
  • [44] Plasma levels and diagnostic value of catestatin in patients with heart failure
    Liu, Lin
    Ding, Wenhui
    Li, Renxu
    Ye, Xiaojin
    Zhao, Jing
    Jiang, Jie
    Meng, Lei
    Wang, Jie
    Chu, Songyun
    Han, Xiaoning
    Peng, Fen
    PEPTIDES, 2013, 46 : 20 - 25
  • [45] IMPACT OF DEPRESSIVE SYMPTOMS ON ALL-CAUSE MORTALITY IN PATIENTS WITH CONGESTIVE HEART FAILURE AFTER CARDIAC RESYNCHRONIZATION THERAPY
    Pushkarev, G. S.
    Kuznetsov, V. A.
    Fisher, Y. A.
    Soldatova, A. M.
    Sapozhnikova, A. D.
    Enina, T. N.
    KARDIOLOGIYA, 2019, 59 (01) : 5 - 11
  • [46] Association of Candesartan vs Losartan With All-Cause Mortality in Patients With Heart Failure
    Hasenoehrl, Norbert
    JOURNAL FUR KARDIOLOGIE, 2011, 18 (3-4): : 108 - 109
  • [47] Association of Candesartan vs Losartan With All-Cause Mortality in Patients With Heart Failure
    Eklind-Cervenka, Maria
    Benson, Lina
    Dahlstrom, Ulf
    Edner, Magnus
    Rosenqvist, Marten
    Lund, Lars H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (02): : 175 - 182
  • [48] Prognosticators of All-Cause Mortality in Patients With Heart Failure With Preserved Ejection Fraction
    Lopuszynski, Jack B.
    Downing, Alicia J.
    Finley, Colleen M.
    Zahid, Maliha
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 158 : 66 - 73
  • [49] Dapagliflozin and All-Cause Hospitalizations in Patients With Heart Failure With Preserved Ejection Fraction
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Jhund, Pardeep
    Miao, Zi Michael
    Boer, Rudolf A. de
    Lam, Carolyn S. P.
    Desai, Akshay S.
    Bengsston, Olof
    McMurray, John J. V.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (10) : 1004 - 1006
  • [50] Depression as an independent risk factor for all-cause mortality in heart failure patients
    Sokoreli, I. Ioanna
    Geleijnse, G.
    Pauws, S.
    Riistama, J.
    Tesanovic, A.
    De Vries, G-J
    Crundall-Goode, A.
    Goode, K.
    Cleland, J.
    Clark, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 69 - 70
12345